US2010105692A1PendingUtilityA1

Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon

Assignee: MOHENO PHILLIPPriority: Oct 30, 2006Filed: Dec 21, 2009Published: Apr 29, 2010
Est. expiryOct 30, 2026(~0.3 yrs left)· nominal 20-yr term from priority
A61P 35/00C07D 475/04A61P 31/00A61P 37/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.

Claims

exact text as granted — not AI-modified
1 .- 3 . (canceled) 
   
   
       4 . A method of treating disease in a subject comprising the administration of a therapeutically effective amount of a compound of formula (I):
   M(pterin) x (H2O) y      wherein:   M is a bivalent metal ion selected from the group consisting of Ca 2+ , Cu 2+ , Mg 2+ , V 2+ , Cr 2+ , Mn 2+ , Fe 2+ , Mo 2+ , Zn 2+ , Sr 2+ , Ba 2+ , Ra 2+ , Ru 2+ , Rh 2+ , Pd 2+ , Cd 2+ , Sn 2+ , W 2+ , Re 2+ , Os 2+ , Ir 2+ , Pt 2+ , Si 2+ , and Sm 2+ ;   X is an integer from 1 to 8; and   y is an integer of from 1 to 8.   
   
   
       5 . The method of  claim 4  wherein the compound of formula (I) is dipterinyl calcium pentahydrate (DCP). 
   
   
       6 . The method of  claim 5  wherein the disease is a neoplastic disease. 
   
   
       7 . The method of  claim 5  wherein the disease is an infectious disease. 
   
   
       8 . The method of  claim 6  comprising modulating tryptophan degradation. 
   
   
       9 . The method of  claim 6  comprising modulating neopterin production. 
   
   
       10 . The method of  claim 6  comprising modulating IFN-γ production. 
   
   
       11 . The method of  claim 6  comprising modulating the activity of the enzyme IDO. 
   
   
       12 . The method of  claim 6  comprising modulating immune resistance in human solid tumors. 
   
   
       13 .- 21 . (canceled)

Join the waitlist — get patent alerts

Track US2010105692A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.